FULL PAPER
DOI: 10.1002/chem.201103129
Quantifying Homo- and Heteromolecular Hydrogen Bonds as a Guide for
Adduct Formation
Amit Delori,[a] Peter T. A. Galek,[b] Elna Pidcock,[b] and William Jones*[a]
Abstract: An investigation into the
predictability of molecular adduct for-
mation is presented by using the ap-
proach of hydrogen bond propensity.
Along with the predictions, crystallisa-
tion reactions (1a–1j) were carried out
between the anti-malarial drug pyri-
methamine (1) and the acids oxalic (a),
malonic (b), acetylenedicarboxylic (c),
adipic (d), pimelic (e), suberic (f), aze-
laic acids (g), as well as hexachloroben-
zene (h), 1,4-diiodobenzene (i), and
1,4-diiodotetrafluorobenzene (j); seven
(1a to 1g) of these successfully formed
salts. Five of these seven salts were
found to be either hydrated or solvat-
ed. Hydrogen bond propensity calcula-
tions predict that hydrogen bonds be-
tween 1 and acids a–g are more likely
to form rather than the H bonds in-
volved in self-association, providing
a rationale for the observation of the
seven new salts. In contrast, propensity
of hydrogen bonds between 1 and h–j
is much smaller as compared to other
bonds predicted for self-association/sol-
vate formation, in agreement with the
observed unsuccessful reactions.
Keywords: computer chemistry
·
cocrystallization · hydrogen bonds ·
knowledge-based predictions · phar-
maceutical materials
Introduction
successes or failures in salt or co-crystal formation in order
to suggest or prioritise experimental work more effectively.
Identifying when solvate formation would be the likely out-
come would also be beneficial.
Molecular adducts (e.g., salts and co-crystals) are considered
as alternatives when the physiochemical properties of
a parent drug molecule are unsuitable or inadequate for sat-
isfactory formulation.[1] Considerable variation in such phar-
maceutically important physical properties as solubility,[2]
dissolution rate,[2i] bioavailability,[3] melting point,[2h,4] stabili-
ty[5] and tableting properties[6] can be achieved by such salt
or co-crystal formation. The synthesis of pharmaceutical
salts and co-crystals can, however, be difficult, especially if
the drug molecule lacks strong hydrogen bond donor and/or
acceptor functionality.[7] Competition with solvate formation
is also a factor that can influence the outcome. Frequently,
supramolecular chemists rely on their experience and empir-
ical knowledge for the judicial choice of an appropriate
counter molecule or ion, and the Cambridge Structural Da-
tabase (CSD) can be queried for specific, informative, exam-
ples.
Molecular adducts involving multiple neutral species, so-
called co-crystals, are of particular current interest.[1a] A dif-
ficulty, however, is a generally low success rate of co-crystal-
lisation reactions making co-crystal screening a time-con-
suming process. Several strategies have been developed for
choosing appropriate counter molecules (coformers).
Hunter and co-workers have proposed a computational
method for co-crystal screening,[8] and Price and colleagues
proposed difference in lattice energy of adduct and reactants
as a criteria for predicting adduct formation.[9] Additionally,
Fꢀbiꢀn and co-workers proposed that coformers chosen
based upon similarity in shape descriptors can increase the
success of a co-crystallisation reaction.[10]
To date the supramolecular synthon approach is the most
widely used guide for the formation of salts or co-crystals.[11]
This approach suggests that molecules with complementary
functional groups can interact to form an adduct. This syn-
thon approach can, however, be less applicable in cases of
multi-functional molecules,[12] which are frequently of inter-
est to the pharmaceutical industry. The synthon approach is
qualitative in nature, takes into consideration only the com-
plementarity of the functional groups and neglects other im-
portant factors, such as steric effects,[13] which can prove
vital for the effectiveness of a given interaction. The Cam-
bridge Crystallographic Data Centre has developed a hydro-
gen bond propensity tool[13b,14] that can be applied to predict
the possibility of new polymorphs or adducts based on the
potential H bonds that might form. On providing informa-
tion of molecular structure, the software searches the CSD
Supramolecular chemists, especially those working with
complex drug molecules in the pharmaceutical industry,
would benefit from being able to predict the likelihood of
[a] Dr. A. Delori, Prof. W. Jones
Department of Chemistry, University of Cambridge
Cambridge, CB2 1EW (UK)
Fax : (+44)1223-336-017
[b] Dr. P. T. A. Galek, Dr. E. Pidcock
Cambridge Crystallographic Data Centre
12 Union Road, Cambridge, CB2 1EZ (UK)
Supporting information for this article is available on the WWW
Chem. Eur. J. 2012, 00, 0 – 0
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
1
&
ÞÞ
These are not the final page numbers!